We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Linked to Lymphatic Abnormalities

By LabMedica International staff writers
Posted on 11 Jul 2013
Genetic analysis and a new lymphatic imaging technique, has shown that the lymphatics are involved in a rare vascular disorder.

When the lymphatics are not functioning, malnutrition, infection and severe edema can ultimately result, which further complicates the diagnosis and treatment of vascular disorders.

Scientists at the University of Texas Health Science Center (Houston, TX, USA) imaged the lymphatics in a patient with a suspected RAS (rat sarcoma) p21 protein activator 1 (RASA1) gene mutation that is known to be linked to Parkes-Weber syndrome (PKWS). More...
This syndrome presents with capillary malformations and arteriovenous fistulas that are associated with abnormal bleeding and heart failure. Imaging techniques included near-infrared fluorescence lymphatic imaging (NIRFLI) developed using military grade night-vision goggle technology.

The investigators used state-of-the-art whole exome sequencing techniques and bioinformatics techniques, and then singled out RASA1 as the only potential causative gene of the disorder in the human research subject. They confirmed the human subject findings in a mouse model developed at the University of Michigan (Ann Arbor, MI, USA). The mouse model not only had a similar RASA1 mutation to the human subject, but a similarly abnormal lymphatic system as imaged by NIRFLI. The team's genetic discovery could be used to identify future pharmacologic strategies to alleviate more common-lymphatic disorders

Eva Sevick-Muraca, PhD, the senior author of the study said, “This study is a game changer. This is a rare case in which we were able to image lymphatic abnormalities in both a patient and a mouse model that harbored similar mutations known only to be associated with vascular malformations. The striking results underscore the potential role of the lymphatics in vascular disorders." The study was published on May 21, 2013, in the journal Proceedings of the National Academy of Sciences of the Unites States of America (PNAS).

Related Links:
University of Texas Health Science Center
University of Michigan



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.